IL116584A0 - Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase - Google Patents

Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase

Info

Publication number
IL116584A0
IL116584A0 IL11658495A IL11658495A IL116584A0 IL 116584 A0 IL116584 A0 IL 116584A0 IL 11658495 A IL11658495 A IL 11658495A IL 11658495 A IL11658495 A IL 11658495A IL 116584 A0 IL116584 A0 IL 116584A0
Authority
IL
Israel
Prior art keywords
adenine dinucleotide
monoamine oxidase
flavin adenine
dinucleotide analogue
analogue inhibitors
Prior art date
Application number
IL11658495A
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/449,311 external-priority patent/US5756479A/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL116584A0 publication Critical patent/IL116584A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
IL11658495A 1994-12-29 1995-12-27 Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase IL116584A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36578294A 1994-12-29 1994-12-29
US08/449,311 US5756479A (en) 1994-12-29 1995-05-24 Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase

Publications (1)

Publication Number Publication Date
IL116584A0 true IL116584A0 (en) 1996-03-31

Family

ID=27003091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11658495A IL116584A0 (en) 1994-12-29 1995-12-27 Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase

Country Status (3)

Country Link
AU (1) AU4745496A (en)
IL (1) IL116584A0 (en)
WO (1) WO1996020946A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610376D0 (en) * 1996-05-17 1996-07-24 Univ Leicester Enzyme-electron acceptor assembly
GB2330143B (en) * 1996-05-17 2000-04-05 Univ Leicester Enzyme-electron acceptor assembly
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5523107B2 (en) 2006-11-30 2014-06-18 プロビオドルグ エージー Novel inhibitors of glutaminyl cyclase
NZ579310A (en) 2007-03-01 2012-03-30 Probiodrug Ag Use of glutaminyl cyclase inhibitors for the treatment of mild cognitive impairment and diagnostic purposes thereof
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8269019B2 (en) 2010-03-10 2012-09-18 Probiodrug Ag Inhibitors
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
JP6050264B2 (en) 2011-03-16 2016-12-21 プロビオドルグ エージー Benzimidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (en) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitors of glutaminyl cyclase

Also Published As

Publication number Publication date
AU4745496A (en) 1996-07-24
WO1996020946A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
IL99759A0 (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan and their use as inhibitor of monoamine oxidase
IL116584A0 (en) Novel flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
AU4430389A (en) Inhibitors of lysyl oxidase
EP1738717A3 (en) In vitro production of transplantable cartilage tissue
AU2008888A (en) Physically stable composition and method of use thereof for osseous repair
AU4065397A (en) Stable compositions for nucleic acid amplification and sequencing
AU3612895A (en) Purine and guanine compounds as inhibitors of pnp
AU7769887A (en) Apparatus and methods of culturing motile microorganisms
HUP9801227A3 (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use
AU4047697A (en) Use of microorganisms for processing bioprosthetic tissue
AU1525388A (en) Aqueous-based composition for removing coatings
AU9425798A (en) Method and kit for amplification, sequencing and typing of classical hla class igenes
MX9702163A (en) Compositions and methods for the control of smoking.
GB2204415B (en) Amperometric method for the quantitative determination of 1,4 dihydronicotinamide adenine dinucleotide (nadh) and its phosphorylated derivative in solution.
AU6417198A (en) Cytoprotective agents comprising monoamine oxidase inhibitors
IL134911A0 (en) Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
AU1875988A (en) 5-aralkyl-2-mercaptoimidazole derivatives as dopamine-beta- hydroxylase inhibitors
NO970870D0 (en) Intermediates for dinucleotide and oligonucleotide analogues
AU4328497A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU8920191A (en) Methods and compositions for minimizing inhibition of nucleic acid amplification
AU8898198A (en) Methods of identifying biological agent compositions
ZA9510994B (en) Novel flavin adenine dinucleotide analogue inhibitors of monamine oxidase
GB9625400D0 (en) Culture of micro-organisms
AU2661097A (en) Prolonging survival of transplanted pancreatic cells
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use